Treatment of cancer cachexia in mice by combination of dsRNA-dependent protein kinase inhibitor and medroxyprogesterone acetate

Author：    

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.27, Iss.2, 2012-01, pp. : 579-584

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Suppression of parathyroid hormone-related protein messenger RNA expression by medroxyprogesterone acetate in breast cancer tissues

By Sugimoto T.   Shiba E.   Watanabe T.   Takai S-i.  

Breast Cancer Research and Treatment, Vol. 56, Iss. 1, 1999-07 ,pp. : 11-23

Springer Publishing Company

Access to resources Recommend Favorite

Apoptosis inhibition mediated by medroxyprogesterone acetate treatment of breast cancer cell lines

By Ory K.  

Breast Cancer Research and Treatment, Vol. 68, Iss. 3, 2001-08 ,pp. : 187-198

Springer Publishing Company

Access to resources Recommend Favorite

Medroxyprogesterone Acetate Reduces the In Vitro Production of Cytokines and Serotonin Involved in Anorexia/cachexia and Emesis by Peripheral Blood Mononuclear Cells of Cancer Patients

By Mantovani G.   Maccio A.   Esu S.   Lai P.   Santona M.C.   Massa E.   Dessi D.   Melis G.B.   Del Giacco G.S.  

European Journal of Cancer, Vol. 33, Iss. 4, 1997-04 ,pp. : 602-607

Elsevier

Access to resources Recommend Favorite

Raf kinase inhibitor protein (RKIP) in cancer

By Escara-Wilke June  

Cancer and Metastasis Reviews, Vol. 31, Iss. 3-4, 2012-12 ,pp. : 615-620

Springer Publishing Company

Access to resources Recommend Favorite

Cyclin Dependent Kinase as Significant Target for Cancer Treatment

By  

Current Cancer Therapy Reviews, Vol. 8, Iss. 3, 2012-08 ,pp. : 225-235

Bentham Science Publishers

Access to resources Recommend Favorite